PYC Therapeutics (PYC.AX) Earnings Analysis
PYC Therapeutics (PYC.AX) next reports earnings on 2026-08-27, consensus EPS -0.04183 AUD. Last quarter (2026-02-22) it beat with EPS -0.0391 AUD vs -0.06543 AUD est (+40.2%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -19.82.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PYC.AX next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | -0.04183 AUD |
| Revenue estimate | n/a |
PYC.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-22 | -0.0391 AUD | -0.06543 AUD | +40.2% | Beat |
| 2024-10-25 | -0.00552 AUD | -0.06962 AUD | +92.1% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
PYC.AX valuation and analyst view
| Trailing P/E | -19.82 |
|---|---|
| Trailing EPS | -0.07963 AUD |
| Price / book | 6.80 |
| Dividend yield | 0.00% |
| Market cap | 0.94B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is PYC Therapeutics (PYC.AX)'s next earnings date?
PYC Therapeutics is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -0.04183 AUD.
Did PYC.AX beat earnings last quarter?
In its 2026-02-22 report, PYC.AX posted EPS of -0.0391 AUD versus a -0.06543 AUD estimate — a beat of 40.2%.
What is PYC.AX's earnings track record?
Over the last 2 reported quarters with consensus data, PYC.AX beat estimates 2 times (100%).
What is PYC.AX's current P/E ratio and EPS?
PYC.AX trades at a trailing P/E of -19.82 on trailing EPS of -0.07963161991945457 AUD.
What do analysts rate PYC.AX?
PYC.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.